These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25822630)

  • 21. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
    Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
    Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice.
    Sugiyama K; Tanaka K
    Biochem Biophys Res Commun; 2018 Mar; 497(2):689-693. PubMed ID: 29458024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
    Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection.
    Wang Z; Liu J; Chen S; Wang Y; Cao L; Zhang Y; Kang W; Li H; Gui Y; Chen S; Ding J
    Ann Neurol; 2011 Oct; 70(4):591-9. PubMed ID: 21796667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
    Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
    Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-specific overexpression of the co-chaperone Bcl-2-associated athanogene-1 in superoxide dismutase 1(G93A)-transgenic mice.
    Rohde G; Kermer P; Reed JC; Bähr M; Weishaupt JH
    Neuroscience; 2008 Dec; 157(4):844-9. PubMed ID: 18955116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
    Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
    Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1.
    Kraft AD; Resch JM; Johnson DA; Johnson JA
    Exp Neurol; 2007 Sep; 207(1):107-17. PubMed ID: 17631292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
    Obrador E; Salvador R; Marchio P; López-Blanch R; Jihad-Jebbar A; Rivera P; Vallés SL; Banacloche S; Alcácer J; Colomer N; Coronado JA; Alandes S; Drehmer E; Benlloch M; Estrela JM
    Mol Neurobiol; 2021 Apr; 58(4):1345-1371. PubMed ID: 33174130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
    Peviani M; Cheroni C; Troglio F; Quarto M; Pelicci G; Bendotti C
    Mol Cell Neurosci; 2007 Apr; 34(4):592-602. PubMed ID: 17303436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.